Immune therapy.

Dr. Cunningham-Rundles has nearly 30 years experience with medical immune deficiency disorders with a research focus of human being immunodeficiency diseases and immuno-reconstitution. Octapharma AG, among the largest human proteins products manufacturers in the world, launched the Octapharma Grants plan last year in special event of the biopharmaceutical company’s 25th anniversary. The company’s first ever grants plan is only available to researchers based in the United States and can be administered by Octapharma USA, the Swiss company’s U.S.Related Stories3D printed heart models to aid doctors arrange for complex ops'Identifying obstructive coronary artery disease in ladies: an interview with Dr. Ladapo, NYU College of MedicinePreclinical Magnetic Particle Imaging: an interview with Professor Jeff Bulte, Johns HopkinsIt involves overlaying CT images of the lungs taken during inhalation and exhalation. A different color is normally assigned to each small 3D area, referred to as voxels, according to the difference in the density measured between your two scans, which indicates whether tissue is diseased or healthy.